PlatPhorm Podcasts

The fast evolution of GLP-1 medications raises questions about safety and side effects

All Sides with Amy Juravich · March 5, 2026

The fast evolution of GLP-1 medications raises questions about safety and side effects artwork

episode · Checking source

The fast evolution of GLP-1 medications raises questions about safety and side effects

All Sides with Amy Juravich

GLP-1 medications are evolving quickly. There’s no longer just Ozempic and Mounjaro. There are more than five types of the drugs across at least one dozen different brands. Plus, a new pill version is hitting the market, which is easier to administer than the shots. As the drugs get cheaper and easier to take, people are asking questions about potential side effects, long-term safety and regulation. Some experts are also asking how appetite-suppressing medications are changing our relationship with food — and what that means for eating disorders and nutrition We will unpack the updates, benefits and risks from a medical, nutrition and psychological perspective. Guests: Ken Alltucker, consumer health reporter, USA Today Dr. Aradhna Saraswat, physician/assistant professor, Center for Women’s Health, Wexner Medical Center Zoe Ross-Nash, PsyD, licensed clinical psychologist/certified eating disorder specialist/founder, Equilibrium Health Advantage If you have a disability and would like a transcript or other accommodation you can request an alternative format . (photo: David J. Phillip / AP)

View original

GLP-1 medications are evolving quickly. There’s no longer just Ozempic and Mounjaro. There are more than five types of the drugs across at least one dozen different brands. Plus, a new pill version is hitting the market, which is easier to administer than the shots. As the drugs get cheaper and easier to take, people are asking questions about potential side effects, long-term safety and regulation. Some experts are also asking how appetite-suppressing medications are changing our relationship with food — and what that means for eating disorders and nutrition We will unpack the updates, benefits and risks from a medical, nutrition and psychological perspective. Guests: Ken Alltucker, consumer health reporter, USA Today Dr. Aradhna Saraswat, physician/assistant professor, Center for Women’s Health, Wexner Medical Center Zoe Ross-Nash, PsyD, licensed clinical psychologist/certified eating disorder specialist/founder, Equilibrium Health Advantage If you have a disability and would like a transcript or other accommodation you can request an alternative format . (photo: David J. Phillip / AP)

Published
March 5, 2026
Status
active
GUID hash
9cbf2b64d98a6db0d9e387cb2863694ffa34ae7f6e156dea6d9d55d628fa8e4a
Archive key
the-fast-evolution-of-glp-1-medications-raises-questions-about-safety-and-side-effects--entry_f07e13ba4dfe81ce9c065559c32b
Archive id
entry_f07e13ba4dfe81ce9c065559c32b